High-performance product lines and the development of new technologies and products
First written in FY2016. 25 of 31 entries say "Restated". Latest entry: FY2026.
32 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The centralized reorganization based on the research-unit structure launched in fiscal 2024 is progressing steadily toward optimizing the allocation of R&D resources and strengthening internal collaboration. Total R&D expenses incurred by the Group during the consolidated fiscal year amounted to ¥2,490 million, equivalent to 1.7% of net sales. Development of microbial carriers for food-waste treatment equipment is also progressing steadily, with specific results achieved.」
The company has disclosed progress in reorganizing its R&D structure, R&D expenses of ¥2,490 million, and specific development results, including microbial carriers. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the consolidated interim accounting period were ¥1,211 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,211 million for the consolidated interim accounting period. No new achievements involving new technologies or products are described. - FY2024AdvancedAnnual report
「In addition, through the planned centralized reorganization of the R&D structure in fiscal 2024, the company will promote faster R&D by optimizing the allocation of R&D resources and strengthening internal collaboration.」
The company plans to invest ¥2,361 million in R&D and is implementing resource optimization and faster development through the reorganization of its R&D structure in fiscal 2024. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥1,762 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,762 million for the cumulative third quarter of the consolidated fiscal year. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,148 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,148 million for the cumulative second quarter of the consolidated fiscal year. No new achievements involving new technologies or products are described. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥556 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥556 million for the cumulative first quarter of the consolidated fiscal year. No new achievements involving new technologies or products are described. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥1,690 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,690 million for the cumulative third quarter of the consolidated fiscal year. No new achievements involving new technologies or products are described. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,109 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,109 million for the cumulative second quarter of the consolidated fiscal year. No new achievements involving new technologies or products are described. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥1,625 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,625 million for the cumulative third quarter of the consolidated fiscal year. No new achievements involving new technologies or products are described. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,073 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,073 million for the cumulative second quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥543 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥543 million for the cumulative first quarter. No specific achievements involving new technologies or products are described. - FY2021RestatedAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year amounted to ¥2,246 million, equivalent to 2.2% of net sales, and the Group is working to improve the quality and performance of existing products and develop a new range of high-function products.」
The company invested ¥2,246 million in R&D and continued to improve existing products and develop a range of high-function products. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥1,614 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,614 million for the cumulative third quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,065 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,065 million for the cumulative second quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥531 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥531 million for the cumulative first quarter. No specific achievements involving new technologies or products are described. - FY2020AdvancedAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year amounted to ¥2,312 million, equivalent to 2.0% of net sales, and, in the non-foamed segment, design sheets with checker-glass and figured-glass patterns have already been launched as partial alternatives to heavy, breakable decorative glass」
The company invested ¥2,312 million in R&D and launched design sheets, while continuing to develop new products and applications, including high-performance insulation materials and Super Blow. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current fiscal year were ¥1,726 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,726 million for the cumulative third quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,153 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,153 million for the cumulative second quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥584 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥584 million for the cumulative first quarter. No specific achievements involving new technologies or products are described. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥1,613 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,613 million for the cumulative third quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2019-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter under review were ¥1,052 million.」
The company has continued its R&D activities and disclosed R&D expenses of ¥1,052 million for the cumulative second quarter of the consolidated fiscal year. No specific achievements involving new technologies or products are described. - FY2019-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter under review were ¥520 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥520 million for the cumulative first quarter. No specific achievements involving new technologies or products are stated. - FY2018AdvancedAnnual report
「The Group's total research and development expenses for the consolidated fiscal year were ¥2,123 million, equivalent to 1.9% of net sales. By segment, ¥739 million was attributable to the extrusion business, ¥796 million to the bead business and ¥586 million to corporate expenses not attributable to any reporting segment.” “In the non-foamed products field, the company successfully developed a resin sheet with an antique glass appearance.」
The company disclosed research and development expenses of ¥2,123 million and reported the specific achievement of successfully developing a resin sheet with an antique glass appearance. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter under review were ¥1,592 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥1,592 million for the cumulative third quarter under review. No specific achievements involving new technologies or products are stated. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter under review were ¥1,047 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥1,047 million for the cumulative second quarter under review. No specific achievements involving new technologies or products are stated in this disclosure. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter under review were ¥515 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥515 million for the cumulative first quarter. No specific achievements involving new technologies or products are stated. - FY2017AdvancedAnnual report
「In the food packaging field, the company developed a heat-resistant expanded polystyrene sheet with added value for microwaveable containers, where demand is expanding. …The company has nearly established manufacturing technology for high-expansion-ratio products and aims to develop new applications.」
The company reported specific progress in research and development, including the development of a new product for microwaveable containers, near-establishment of manufacturing technology for high-expansion-ratio products and an increase in vehicle models adopting Super Foam for automotive applications. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter under review were ¥1,598 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥1,598 million for the cumulative third quarter under review. No specific achievements involving new technologies or products are stated. - FY2017-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter under review were ¥1,056 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥1,056 million for the cumulative quarter under review. No specific achievements involving new technologies or products are stated. - FY2017-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter under review were ¥522 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥522 million for the quarter. No specific achievements involving new technologies or products are stated. - FY2016First statedAnnual report
「The two research institutes are using the Group's core foaming technology and related proprietary technologies to improve the quality and performance of existing products and develop new high-performance product lines.」
The company is advancing improvements to existing products and developing high-performance product lines, primarily at the Kanuma and Yokkaichi Research Institutes. Research and development expenses for the fiscal year were ¥2,034 million, or 1.8% of net sales.